Sign Up to like & get
recommendations!
0
Published in 2019 at "OncoTargets and therapy"
DOI: 10.2147/ott.s223946
Abstract: Abstract Leukemia immunotherapy has been dominant via using synthetic antibodies to target cluster of differentiation (CD) molecules, nevertheless inevitable cytotoxicity and immunogenicity would limit its development. Recently, increasing reports have focused on nucleic acid aptamers,…
read more here.
Keywords:
leukemia;
acid aptamer;
nucleic acid;
novel potential ... See more keywords